Stanley-Laman Group LTD Lowered Its Monsanto Co (MON) Holding by $733,932; Johnson & Johnson (JNJ) Stock Price Declined While Fragasso Group Trimmed Stake

April 22, 2018 - By Marie Mckinney

Monsanto Company (NYSE:MON) Logo

Stanley-Laman Group Ltd decreased its stake in Monsanto Co (MON) by 36.75% based on its latest 2017Q4 regulatory filing with the SEC. Stanley-Laman Group Ltd sold 6,327 shares as the company’s stock rose 1.12% while stock markets declined. The institutional investor held 10,889 shares of the agricultural chemicals company at the end of 2017Q4, valued at $1.27M, down from 17,216 at the end of the previous reported quarter. Stanley-Laman Group Ltd who had been investing in Monsanto Co for a number of months, seems to be less bullish one the $55.16 billion market cap company. The stock increased 0.32% or $0.4 during the last trading session, reaching $125. About 3.71 million shares traded. Monsanto Company (NYSE:MON) has risen 3.06% since April 22, 2017 and is uptrending. It has underperformed by 8.49% the S&P500.

Fragasso Group Inc decreased its stake in Johnson & Johnson (JNJ) by 11.73% based on its latest 2017Q4 regulatory filing with the SEC. Fragasso Group Inc sold 2,636 shares as the company’s stock declined 9.21% with the market. The institutional investor held 19,844 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $2.77M, down from 22,480 at the end of the previous reported quarter. Fragasso Group Inc who had been investing in Johnson & Johnson for a number of months, seems to be less bullish one the $339.78 billion market cap company. The stock decreased 0.70% or $0.89 during the last trading session, reaching $126.66. About 7.74M shares traded. Johnson & Johnson (NYSE:JNJ) has risen 1.12% since April 22, 2017 and is uptrending. It has underperformed by 10.43% the S&P500.

Since February 15, 2018, it had 0 insider buys, and 1 sale for $20.17 million activity.

Fragasso Group Inc, which manages about $853.06M and $411.59M US Long portfolio, upped its stake in Pimco Etf Tr (BOND) by 5,522 shares to 55,006 shares, valued at $5.83M in 2017Q4, according to the filing. It also increased its holding in Ishares Tr by 53,162 shares in the quarter, for a total of 374,075 shares, and has risen its stake in Vanguard Index Fds (VOO).

Investors sentiment increased to 0.87 in Q4 2017. Its up 0.04, from 0.83 in 2017Q3. It increased, as 35 investors sold JNJ shares while 884 reduced holdings. 143 funds opened positions while 654 raised stakes. 1.72 billion shares or 0.40% more from 1.71 billion shares in 2017Q3 were reported. Empirical Fincl Service Ltd Liability Corporation has 0.19% invested in Johnson & Johnson (NYSE:JNJ) for 6,317 shares. New England Private Wealth Ltd Com invested in 6,753 shares or 0.27% of the stock. Moreover, Blackhill Capital Incorporated has 4.89% invested in Johnson & Johnson (NYSE:JNJ). Brown Capital Mgmt Ltd Liability, a Maryland-based fund reported 2,437 shares. First Bancorp has invested 2.11% in Johnson & Johnson (NYSE:JNJ). Schwab Charles Invest Inc accumulated 12.58 million shares. Gillespie Robinson Grimm holds 4.1% or 232,055 shares in its portfolio. Private Wealth Advsr has invested 1.85% in Johnson & Johnson (NYSE:JNJ). Ballentine Ltd Liability Corporation invested in 0.18% or 24,179 shares. First City Mngmt Inc accumulated 14,333 shares. Arrowstreet Capital LP invested in 0.29% or 858,392 shares. National Asset Mgmt Inc reported 55,591 shares. Millennium Lc reported 1.01M shares. Carlson Mgmt accumulated 8,791 shares. Comml Bank has invested 1.84% of its portfolio in Johnson & Johnson (NYSE:JNJ).

Among 23 analysts covering Johnson & Johnson (NYSE:JNJ), 11 have Buy rating, 5 Sell and 7 Hold. Therefore 48% are positive. Johnson & Johnson had 100 analyst reports since August 7, 2015 according to SRatingsIntel. On Tuesday, July 18 the stock rating was maintained by Piper Jaffray with “Hold”. The firm earned “Hold” rating on Thursday, August 4 by Jefferies. Leerink Swann maintained it with “Buy” rating and $165.0 target in Wednesday, October 18 report. Barclays Capital upgraded the shares of JNJ in report on Tuesday, December 1 to “Overweight” rating. On Friday, October 6 the stock rating was maintained by Cowen & Co with “Buy”. Citigroup initiated the stock with “Hold” rating in Monday, September 25 report. On Tuesday, July 18 the stock rating was maintained by Stifel Nicolaus with “Hold”. Piper Jaffray reinitiated Johnson & Johnson (NYSE:JNJ) on Monday, October 5 with “Neutral” rating. The firm has “Buy” rating by Cowen & Co given on Tuesday, June 13. BMO Capital Markets maintained it with “Buy” rating and $152.0 target in Tuesday, October 17 report.

Analysts await Monsanto Company (NYSE:MON) to report earnings on June, 27. They expect $2.19 EPS, up 13.47% or $0.26 from last year’s $1.93 per share. MON’s profit will be $966.42 million for 14.27 P/E if the $2.19 EPS becomes a reality. After $3.22 actual EPS reported by Monsanto Company for the previous quarter, Wall Street now forecasts -31.99% negative EPS growth.

Investors sentiment decreased to 0.81 in 2017 Q4. Its down 0.03, from 0.84 in 2017Q3. It worsened, as 69 investors sold MON shares while 328 reduced holdings. 75 funds opened positions while 246 raised stakes. 317.44 million shares or 1.24% less from 321.42 million shares in 2017Q3 were reported. North Star Asset Mgmt reported 0.06% stake. Moreover, Cobblestone Advsr Ltd Liability Com New York has 0.02% invested in Monsanto Company (NYSE:MON) for 2,129 shares. Advisor Prns Lc has 0.15% invested in Monsanto Company (NYSE:MON). 272,210 are owned by Us State Bank De. 125,290 are owned by Westpac. Nelson Roberts Inv Advsrs Limited Liability, a California-based fund reported 460 shares. Moreover, Odey Asset Management Gp has 2.9% invested in Monsanto Company (NYSE:MON) for 273,091 shares. Cullinan Assoc reported 70,760 shares stake. Wealthcare Cap Management Limited Liability stated it has 0% of its portfolio in Monsanto Company (NYSE:MON). Kanawha Management Ltd Liability Corp holds 0.03% or 1,804 shares. Oppenheimer Asset Inc holds 0.01% or 2,262 shares. Public Sector Pension Invest Board reported 0.14% of its portfolio in Monsanto Company (NYSE:MON). Bryn Mawr reported 0.04% in Monsanto Company (NYSE:MON). Great Lakes Advsr Ltd Limited Liability Company stated it has 0.03% of its portfolio in Monsanto Company (NYSE:MON). Calamos Advsrs Ltd Liability stated it has 54,157 shares or 0.03% of all its holdings.

Stanley-Laman Group Ltd, which manages about $747.00 million and $463.08M US Long portfolio, upped its stake in Proofpoint Inc (NASDAQ:PFPT) by 63,241 shares to 71,461 shares, valued at $6.35M in 2017Q4, according to the filing. It also increased its holding in Neurocrine Bioscienc (NASDAQ:NBIX) by 33,723 shares in the quarter, for a total of 89,146 shares, and has risen its stake in Merck & Co Inc (NYSE:MRK).

Since January 9, 2018, it had 0 insider buys, and 1 sale for $966,720 activity.

Among 23 analysts covering Monsanto Company (NYSE:MON), 10 have Buy rating, 1 Sell and 12 Hold. Therefore 43% are positive. Monsanto Company had 63 analyst reports since August 25, 2015 according to SRatingsIntel. The company was upgraded on Tuesday, September 27 by Goldman Sachs. The rating was maintained by Stifel Nicolaus on Friday, October 9 with “Buy”. As per Tuesday, June 14, the company rating was maintained by UBS. The stock of Monsanto Company (NYSE:MON) earned “Buy” rating by Canaccord Genuity on Thursday, August 27. The company was maintained on Tuesday, August 1 by RBC Capital Markets. The firm has “Hold” rating by Jefferies given on Monday, August 14. The stock has “Hold” rating by RBC Capital Markets on Monday, November 13. The stock has “Neutral” rating by JP Morgan on Thursday, April 7. Piper Jaffray maintained it with “Overweight” rating and $133 target in Thursday, August 27 report. The stock of Monsanto Company (NYSE:MON) earned “Neutral” rating by Susquehanna on Tuesday, June 27.

Johnson & Johnson (NYSE:JNJ) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>